{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:52:19Z","timestamp":1793638339818,"version":"4.5.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10928-015-9404-6","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T15:25:32Z","timestamp":1422372332000},"page":"111-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery"],"prefix":"10.1007","volume":"42","author":[{"given":"Krzysztof","family":"Przyby\u0142owski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Tyczka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Szczesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Bienert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Wiczling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Plenzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kaliszan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Grze\u015bkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"9404_CR1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00000542-198908000-00015","volume":"71","author":"PS Sebel","year":"1989","unstructured":"Sebel PS, Lowdon JD (1989) Propofol: a new intravenous anaesthetic. Anesthesiology 71:260\u2013277","journal-title":"Anesthesiology"},{"key":"9404_CR2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1079-2104(99)70129-0","volume":"87","author":"JE Cillo Jr","year":"1999","unstructured":"Cillo JE Jr (1999) Propofol anaesthesia for outpatient oral and maxillofacial surgery. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 87:530\u2013538","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol"},{"key":"9404_CR3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/978-1-4419-0184-2","volume-title":"Principles and practice of anesthesia for thoracic surgery","author":"MD Slinger","year":"2011","unstructured":"Slinger MD (2011) In: Slinger P (ed) Principles and practice of anesthesia for thoracic surgery. Springer, New York, p 732"},{"key":"9404_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/bja\/aep143","volume":"103","author":"AR Absalom","year":"2009","unstructured":"Absalom AR, Mani V, Smet TD, Struys MMRF (2009) Pharmacokinetic models for propofol-defining and illuminating the devil in the detail. Br J Anaesth 103:26\u201337","journal-title":"Br J Anaesth"},{"key":"9404_CR5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2125.1999.00860.x","volume":"47","author":"JX Mazoit","year":"1999","unstructured":"Mazoit JX, Samii K (1999) Binding of propofol to blood components: implications for pharmacokinetics and for pharmacodynamics. Br J Clin Pharmacol 47:35\u201342","journal-title":"Br J Clin Pharmacol"},{"key":"9404_CR6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF03261930","volume":"51","author":"J Diepstraten","year":"2012","unstructured":"Diepstraten J, Chidambaran V, Sadhasivam S, Esslinger HR, Cox SL, Inge TH, Knibbe CAJ, Vinks AA (2012) Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Clin Pharmacokinet 51:543\u2013551","journal-title":"Clin Pharmacokinet"},{"key":"9404_CR7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/sj.clpt.6100309","volume":"83","author":"MYM Peeters","year":"2008","unstructured":"Peeters MYM, Bras LJ, DeJongh J, Wesselink RMJ, Aarts LPHJ, Danhof M, Knibbe CAJ (2008) Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients. Clin Pharmacol Ther 83:443\u2013451","journal-title":"Clin Pharmacol Ther"},{"key":"9404_CR8","first-page":"545","volume":"61","author":"A Bienert","year":"2011","unstructured":"Bienert A, Wiczling P, Zaba C, Zaba Z, Wolc A, Marciniak R, Grze\u015bkowiak E, Kusza K (2011) Influence of demographic factors, basic blood test parameters and opioid type on propofol pharmacokinetics and pharmacodynamics in ASA I-III patients. Arzneimittelforschung 61:545\u2013552","journal-title":"Arzneimittelforschung"},{"key":"9404_CR9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.clpt.2003.12.004","volume":"75","author":"H Hiraoka","year":"2004","unstructured":"Hiraoka H, Yamamoto K, Okano N, Morita T, Goto F, Horiuchi R (2004) Changes in drug plasma concentrations of an extensively bound and highly extracted drug, propofol, in response to altered plasma binding. Clin Pharmacol Ther 75:324\u2013330","journal-title":"Clin Pharmacol Ther"},{"key":"9404_CR10","first-page":"855","volume":"81","author":"C Guellec Le","year":"1995","unstructured":"Le Guellec C, Lacarelle B, Villard PH, Point H, Catalin J, Durand A (1995) Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs. Anesth Analg 81:855\u2013861","journal-title":"Anesth Analg"},{"key":"9404_CR11","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1734-1140(12)70874-5","volume":"64","author":"A Bienert","year":"2012","unstructured":"Bienert A, Wiczling P, Grze\u015bkowiak E, Cywi\u0144ski JB, Kusza K (2012) Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics. Pharmacol Rep 64:782\u2013795","journal-title":"Pharmacol Rep"},{"key":"9404_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1213\/01.ANE.0000147519.82841.5E","volume":"100","author":"TG Monk","year":"2005","unstructured":"Monk TG, Saini V, Weldon BC, Sigl JC (2005) Anesthetic management and one-year mortality after non-cardiac surgery. Anesth Analg 100:4\u201310","journal-title":"Anesth Analg"},{"key":"9404_CR13","first-page":"106","volume":"2","author":"GL Snyder","year":"2011","unstructured":"Snyder GL, Greenberg S (2011) Effect of anaesthetic technique and other perioperative factors on cancer reccurence. Br J Anaesth 2:106\u2013115","journal-title":"Br J Anaesth"},{"key":"9404_CR14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1213\/ANE.0b013e3182a6d2f8","volume":"117","author":"J Bresson","year":"2013","unstructured":"Bresson J, Liu N, Fischler M, Bresson A (2013) Anesthesia, sleep and death: from mythology to the operating room. Anesth Analg 117:1257\u20131259","journal-title":"Anesth Analg"},{"key":"9404_CR15","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/00000542-199805000-00006","volume":"88","author":"TW Schnider","year":"1998","unstructured":"Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, Youngs EJ (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88:1170\u20131182","journal-title":"Anesthesiology"},{"key":"9404_CR16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1213\/ANE.0000000000000165","volume":"118","author":"DJ Eleveld","year":"2014","unstructured":"Eleveld DJ, Proost JH, Cortinez LI, Absalom AR, Struys MM (2014) A general purpose pharmacokinetic model for propofol. Anesth Analg 118:1221\u20131237","journal-title":"Anesth Analg"},{"key":"9404_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-4347(87)80394-8","volume":"421","author":"GF Plummer","year":"1987","unstructured":"Plummer GF (1987) Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. J Chromatogr 421:171\u2013176","journal-title":"J Chromatogr"},{"key":"9404_CR18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1099-0801(200006)14:4<249::AID-BMC981>3.0.CO;2-H","volume":"14","author":"AL Dawidowicz","year":"2000","unstructured":"Dawidowicz AL, Fornal E, Fijalkowska A (2000) Determining the influence of storage time on the level of propofol in blood samples by means of chromatography. Biomed Chromatogr 14:249\u2013255","journal-title":"Biomed Chromatogr"},{"key":"9404_CR19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/bmc.269","volume":"17","author":"AL Dawidowicz","year":"2003","unstructured":"Dawidowicz AL, Kality\u0144ski R (2003) HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid. Biomed Chromatogr 17:447\u2013452","journal-title":"Biomed Chromatogr"},{"key":"9404_CR20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000542-200509000-00012","volume":"103","author":"HE Vereecke","year":"2005","unstructured":"Vereecke HE, Vasquez PM, Jensen EW, Thas O, Vandenbroecke R, Mortier EP, Struys MM (2005) New composite index based on midlatency auditory evoked potential and electroencephalographic parameters to optimize correlation with propofol effect site concentration: comparison with bispectral index and solitary used fast extracting auditory evoked potential index. Anesthesiology 103:500\u2013507","journal-title":"Anesthesiology"},{"key":"9404_CR21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","volume":"11","author":"RM Savic","year":"2009","unstructured":"Savic RM, Karlsson MO (2009) Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J 11:558\u2013569","journal-title":"AAPS J"},{"key":"9404_CR22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","volume":"28","author":"SL Beal","year":"2001","unstructured":"Beal SL (2001) Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 28:481\u2013504","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9404_CR23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0169-2607(98)00098-4","volume":"59","author":"J Parke","year":"1999","unstructured":"Parke J, Holford NH, Charles BG (1999) A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Progr Biomed 59:19\u201329","journal-title":"Comput Methods Progr Biomed"},{"key":"9404_CR24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO (2011) Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J 13:143\u2013151","journal-title":"AAPS J"},{"key":"9404_CR25","first-page":"439","volume-title":"Miller\u2019s anesthesia","author":"P Glass","year":"2005","unstructured":"Glass P, Shafer S, Reves J (2005) Intravenous drug delivery systems. In: Miller RD (ed) Miller\u2019s anesthesia, 6th edn. Elsevier, New York, pp 439\u2013480","edition":"6"},{"key":"9404_CR26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1213\/ANE.0b013e3181bdcf5b","volume":"111","author":"K Masui","year":"2010","unstructured":"Masui K, Upton RN, Doufas AG, Coetzee JF, Kazama T, Mortier EP, Struys MM (2010) The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data. Anesth Analg 111:368\u2013379","journal-title":"Anesth Analg"},{"key":"9404_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10928-010-9157-1","volume":"37","author":"MA Bj\u00f6rnsson","year":"2010","unstructured":"Bj\u00f6rnsson MA, Norberg A, Kalman S, Karlsson MO, Simonsson US (2010) A two-compartment effect site model describes the bispectral index after different rates of propofol infusion. J Pharmacokinet Pharmacodyn 37:243\u2013255","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"9404_CR28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00000542-199008000-00004","volume":"73","author":"J Albanese","year":"1990","unstructured":"Albanese J, Martin C, Lacarelle B, Saux P, Durand A, Gouin F (1990) Pharmacokinetics of long-term\u00a0propofol\u00a0infusion used for sedation in ICU patients. Anesthesiology 73:214\u2013217","journal-title":"Anesthesiology"},{"key":"9404_CR29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00000542-200003000-00017","volume":"92","author":"J Sch\u00fcttler","year":"2009","unstructured":"Sch\u00fcttler J, Ihmsen H (2009) Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 92:727\u2013738","journal-title":"Anesthesiology"},{"key":"9404_CR30","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/0952-8180(93)90003-W","volume":"5","author":"SL Shafer","year":"1993","unstructured":"Shafer SL (1993) Advances in propofol pharmacokinetics and pharmacodynamics. J Clin Anesth 5:14S\u201321S","journal-title":"J Clin Anesth"},{"key":"9404_CR31","first-page":"66","volume":"48","author":"DM Steinbacher","year":"2001","unstructured":"Steinbacher DM (2001) Propofol: a sedative-hypnotic anaesthetic agent for use in ambulatory procedures. Anesth Prog 48:66\u201371","journal-title":"Anesth Prog"},{"key":"9404_CR32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/11592890-000000000-00000","volume":"50","author":"S Kralingen Van","year":"2011","unstructured":"Van Kralingen S, Diepstraten J, Peeters MYM, Deneer VHM, Van Ramshorst B, Wiezer RJ, Van Dongen EPA, Danhof M, Knibbe CAJ (2011) Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients. Clin Pharmacokinet 50:739\u2013750","journal-title":"Clin Pharmacokinet"},{"key":"9404_CR33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1734-1140(12)70737-5","volume":"64","author":"P Wiczling","year":"2012","unstructured":"Wiczling P, Bienert A, Sobczy\u0144ski P, Hartmann-Sobczy\u0144ska R, Bieda K, Marcinkowska A, Malaty\u0144ska M, Kaliszan R, Grze\u015bkowiak E (2012) Pharmacokinetics and pharmacodynamics of\u00a0propofol\u00a0in patients undergoing abdominal aortic surgery. Pharmacol Rep 64:113\u2013122","journal-title":"Pharmacol Rep"},{"key":"9404_CR34","first-page":"1389","volume":"125","author":"JD Gao","year":"2012","unstructured":"Gao JD, Zhao YJ, Xu CS, Zhao J, Huang YG, Wang TL, Pei L, Wang J, Yao LN, Ding Q, Tan ZM, Zhu ZR, Yue Y (2012) Evaluation of entropy for monitoring the depth of anesthesia compared with bispectral index: a multicenter clinical trial. Chin Med J 125:1389\u20131392","journal-title":"Chin Med J"},{"key":"9404_CR35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/bja\/aet383","volume":"112","author":"F Fu","year":"2014","unstructured":"Fu F, Chen X, Feng Y, Shen Y, Feng Z, Bein B (2014) Propofol EC50 for inducing loss of consciousness is lower in the luteal phase of the menstrual cycle. Br J Anaesth 112:506\u2013513","journal-title":"Br J Anaesth"},{"key":"9404_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0952-8180(01)00368-3","volume":"14","author":"Z Ozkose","year":"2002","unstructured":"Ozkose Z, Yalcin Cok O, Tuncer B, Tufekcioglu S, Yardim S (2002) Comparison of hemodynamics, recovery profile, and early postoperative pain control and costs of remifentanil versus alfentanil-based total intravenous anaesthesia (TIVA). J Clin Anesth 14:161\u2013168","journal-title":"J Clin Anesth"},{"key":"9404_CR37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00023210-200721020-00006","volume":"21","author":"Z Zaba","year":"2007","unstructured":"Zaba Z, Bienert A, Drobnik L, Dyderski S, Kusza K (2007) Spectral frequency index monitoring during propofol-remifentanil and propofol-alfentanil total intravenous anesthesia. CNS Drugs 21:165\u2013171","journal-title":"CNS Drugs"},{"key":"9404_CR38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0952-8180(02)00510-X","volume":"15","author":"W Mi","year":"2003","unstructured":"Mi W, Sakai T, Kudo T, Kudo M, Matsuki A (2003) The interaction between fentanyl and propofol during emergence from anesthesia with the EEG-bispectral index. J Clin Anesth 15:103\u2013107","journal-title":"J Clin Anesth"},{"key":"9404_CR39","first-page":"445","volume":"52","author":"J Vuyk","year":"2001","unstructured":"Vuyk J (2001) Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interaction. Acta Anaesthesiol Belg 52:445\u2013451","journal-title":"Acta Anaesthesiol Belg"},{"key":"9404_CR40","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/00000542-199906000-00012","volume":"90","author":"MT Chan","year":"1999","unstructured":"Chan MT, Gin T, Poon WS (1999) Propofol requirement is decreased in patients with large supratentorial brain tumor. Anesthesiology 90:1571\u20131576","journal-title":"Anesthesiology"},{"key":"9404_CR41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/bja\/aeg189","volume":"91","author":"S Kreuer","year":"2003","unstructured":"Kreuer S, Bruhn J, Larsen R, Hoepstein M, Wilhelm W (2003) Comparison of Alaris AEP index and bispectral index during propofol-remifentanil anaesthesia Br. J Anaesth 91:336\u2013340","journal-title":"J Anaesth"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-015-9404-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-015-9404-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-015-9404-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T23:13:58Z","timestamp":1553642038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-015-9404-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["9404"],"URL":"https:\/\/doi.org\/10.1007\/s10928-015-9404-6","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}